SILVAPHL Stock Overview
Silva Pharmaceuticals Limited engages in manufacture and marketing of pharmaceutical products in Bangladesh.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Silva Pharmaceuticals Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ৳16.00 |
52 Week High | ৳21.60 |
52 Week Low | ৳15.80 |
Beta | 0.040 |
1 Month Change | -11.60% |
3 Month Change | -25.93% |
1 Year Change | -25.93% |
3 Year Change | -12.57% |
5 Year Change | -35.63% |
Change since IPO | -42.07% |
Recent News & Updates
Recent updates
Shareholder Returns
SILVAPHL | BD Pharmaceuticals | BD Market | |
---|---|---|---|
7D | -2.4% | -1.8% | -1.6% |
1Y | -25.9% | -12.7% | -13.5% |
Return vs Industry: SILVAPHL underperformed the BD Pharmaceuticals industry which returned -12.7% over the past year.
Return vs Market: SILVAPHL underperformed the BD Market which returned -13.5% over the past year.
Price Volatility
SILVAPHL volatility | |
---|---|
SILVAPHL Average Weekly Movement | 5.7% |
Pharmaceuticals Industry Average Movement | 5.5% |
Market Average Movement | 5.7% |
10% most volatile stocks in BD Market | 8.8% |
10% least volatile stocks in BD Market | 3.2% |
Stable Share Price: SILVAPHL's share price has been volatile over the past 3 months.
Volatility Over Time: SILVAPHL's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 594 | Saira Khan | https://www.silvapharma.com |
Silva Pharmaceuticals Limited engages in manufacture and marketing of pharmaceutical products in Bangladesh. The company offers drugs for antibiotics, antifungals, analgesics, anti-diabetics, anti-pyretics, anti-inflammatory, anti-ulcerants, respiratory, cardiovascular, central nervous system, dermatology, gastrointenstinal, antiemetic and anti-spasmodic, antibacterial, allergies, cough, and cold, as well as natural sweetner, vitamins and minerals. It also provides medicine and vaccine for farmers and fisheries; agricultural chemicals and public health insecticides; and herbal and neutraceutical products.
Silva Pharmaceuticals Limited Fundamentals Summary
SILVAPHL fundamental statistics | |
---|---|
Market cap | ৳2.18b |
Earnings (TTM) | -৳28.15m |
Revenue (TTM) | ৳637.53m |
3.4x
P/S Ratio-77.6x
P/E RatioIs SILVAPHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SILVAPHL income statement (TTM) | |
---|---|
Revenue | ৳637.53m |
Cost of Revenue | ৳464.41m |
Gross Profit | ৳173.13m |
Other Expenses | ৳201.28m |
Earnings | -৳28.15m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.21 |
Gross Margin | 27.16% |
Net Profit Margin | -4.42% |
Debt/Equity Ratio | 1.9% |
How did SILVAPHL perform over the long term?
See historical performance and comparison